egfr tki resistance: progress and challenges
Published 3 years ago • 1.3K plays • Length 10:39Download video MP4
Download video MP3
Similar videos
-
8:00
egfr tki resistance: targeting met amplification
-
44:03
egfr: the challenge of primary and secondary resistance
-
21:09
mechanisms of resistance to egfr tki and new treatment strategies
-
2:20
osimertinib in advanced non–small-cell lung cancer
-
8:37
egfr mechanisms of resistance
-
5:32
introduction to egfr inhibitors
-
28:17
segment 1: egfr tkis in nsclc
-
6:02
egfr mutation and cancer
-
3:07
third generation egfr tkis for acquired resistance
-
20:18
understanding, preventing, and delaying egfr resistance in the era of osimertinib
-
20:07
acquired egfr resistance: what are the current therapeutic strategies?
-
2:21
should egfr tki therapy be continued beyond progression?
-
3:17
egfr resistance mechanisms and sequencing strategies
-
20:24
targeted treatment with egfr tkis: front line options
-
5:45
egfr tki sequencing
-
2:46
gefitinib: targeted treatment for egfr mutation-positive lung cancer | glpbio
-
5:03
understanding nsclc treatment when you have an egfr mutation
-
24:36
treatment options for egfr t790m negative acquired resistance
-
6:03
managing resistance to egfr tkis in nsclc
-
14:43
gracecast-070_lung-cancer_q&a for acquired egfr tki and re-biopsying
-
3:48
azd9291, an egfr-tki, for t790m-mediated resistance in non-small cell lung cancer